Engflag

Elimex

Quick links to important sections

Elimex

There is no image.

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Elimex

Property Description
Active ingredient Permethrin
Form Cream, Lotion, Wash (Topical)
Pharmacological class Ectoparasiticide
Common use Elimination of parasitic infestations
Origin Synthetic pyrethroid

What is Elimex and What Type of Medicine is It?

Elimex is a topical medicinal preparation whose primary function is the management and treatment of ectoparasitic infestations. It is fundamentally classified as an ectoparasiticide, a pharmacological class of agents specifically used to eliminate parasites residing on the external body surfaces. The sole active ingredient responsible for this effect is Permethrin, which is used for treating ectoparasitic diseases. This confirms the medicine is clinically recognized for its general role in addressing external parasitic issues. This single-ingredient medicine is typically positioned for human use against organisms such as mites and lice.

Permethrin: Origin, Composition, and Dosage Form

The active component, Permethrin, is defined as a synthetic pyrethroid, developed chemically to enhance the insecticidal activity of naturally occurring compounds found in plants (pyrethrins). This synthetic nature contributes to its stability and optimized action. Elimex is supplied in various topical formulations, typically as a cream or lotion, designed for dermal application directly to the affected area. These forms consist of the active Permethrin dispersed within an inert, hydrophilic base/vehicle, ensuring the formulation is suitable for direct contact with the skin and hair, which is vital for its topical route of administration.

The Foundational Principle of Ectoparasiticide Action

The general therapeutic purpose of Elimex is achieved through its highly targeted action as an arthropod neurotoxin. Permethrin functions by disrupting the normal flow of sodium ions across the nerve cell membranes of the parasite, leading to nerve hyper-excitation and eventual paralysis. Pyrethroids act on the nervous system to disrupt sodium channels. This action establishes the medicine's effective mechanism for achieving definitive termination of the parasitic organism, which is the primary general benefit of the medicine when used to manage an external parasitic infection.

What side effects are possible with Elimex?

The safety profile of Elimex is primarily defined by common, localized reactions that are observed at the application site. Regulatory classification defines these effects based on frequency and affected system-organ classes.

Common Adverse Reactions

The most frequently documented adverse effects fall under Skin and Subcutaneous Tissue Disorders. These are classified as Common and typically occur soon after application. Reported reactions include a burning sensation of the skin, stinging sensation, pruritus (itching), and paraesthesia (numbness or tingling). These effects are generally described in regulatory documents as mild and transient.

Time-Course and Systemic Reports

Symptoms of the underlying infestation, such as pruritus and erythema, may be temporarily exacerbated following treatment application. Notably, post-treatment itching may persist for up to four weeks following successful parasitic elimination, which is documented as a residual reaction to the dead parasites. Post-marketing surveillance has reported rare systemic events, including headache, dizziness, nausea, and vomiting (frequency not known).

Serious Risks and Safety Limitations

A major safety constraint is the potential for Hypersensitivity Reactions (allergic reactions), which are documented as serious adverse events. This medicine is contraindicated in individuals with a known hypersensitivity to the active substance, Permethrin, or related compounds, such as pyrethrins or chrysanthemums. Furthermore, safety and efficacy are not established in children under 2 months of age. Application must strictly avoid contact with the eyes and mucous membranes due to the potential for marked irritation. The excipient (liquid paraffin) contained in the cream formulation may also reduce the integrity of latex barrier products.

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for Elimex (topical permethrin) is predominantly structured around the risk of accidental oral ingestion of the preparation, as excessive dermal application is generally not associated with systemic toxicity. Regulatory documents state that substantial systemic exposure may lead to documented manifestations such as nausea, vomiting, headache, and dizziness. Overdose carries a risk of effects on the Central Nervous System, with potential severe outcomes including convulsions or seizures.

Regulatory authorities mandate that any suspected or actual oral ingestion requires the user to seek immediate medical attention and contact a poison control center without delay. The official approach to management is strictly defined as symptomatic and supportive treatment. This strategy is required because regulatory prescribing information explicitly states that no specific antidote is known for Permethrin toxicity. Depending on the extent of systemic exposure and timing, procedures such as gastric lavage may be considered for treatment following recent ingestion, particularly in a child, as described in the official guidance. Hospital monitoring may be required to observe the patient's neurological status and vital signs.

Therapeutic Uses of Elimex

What Elimex Treats: Main Uses and Benefits

Elimex is a topical preparation commonly used for managing ectoparasitic infestations in humans. It is relevant for managing parasitic skin diseases, specifically addressing scabies (mite infestation) and various forms of pediculosis, including head lice, body lice, and pubic lice.

Management of Scabies and Lice Infestations

Elimex is applied across therapeutic domains where additional symptomatic support is needed to address the visible presence of external parasites. Its application is relevant for managing conditions characterized by periods of heightened symptoms, which supports containment and reduction of the organism's presence. This medicine is also relevant in clinical settings that involve acute or unstable symptom patterns, where containment of contagious skin conditions is needed.

“This supportive approach contributes to improved comfort during periods of heightened symptoms, helping patients cope more steadily.”

The medicine is used for managing symptoms related to physical discomfort, such as pronounced pruritus (itching) and the resulting skin irritation (rashes, papules). It is relevant in contexts where these symptoms may interfere with daily functioning and comfort. By providing symptomatic relief, the medicine helps patients cope more steadily with these manifestations.

Quick Fact: Relief for Pronounced Itching

This use assists with maintaining functional stability and supports general well-being during symptomatic phases, and is commonly used across conditions presenting with acute episodes, often relevant for managing exposed household members or other close contacts.

Regulatory References

  1. NIH MedlinePlus Drug Information overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Elimex?

Eligibility for Elimex (Permethrin) is strictly defined by official regulatory documents.

Contraindicated Populations

The medicine is absolutely contraindicated in any patient with a known hypersensitivity to the active ingredient, Permethrin, to any related compounds such as synthetic pyrethroids or pyrethrins, or to any of the formulation’s inactive components.

Age-Related Eligibility

Elimex is approved for use in adults and children aged two months and older. Use is not established in infants younger than two months of age, as safety and effectiveness data are insufficient for this population.

Conditional Use and Restrictions

Eligibility is restricted by physiological status. For pregnant women, the official classification dictates that the medicine should be used only if clearly needed. Nursing mothers should consider temporarily discontinuing breastfeeding during treatment, as it is unknown if the drug is excreted in human milk. Furthermore, special caution is advised for patients with known allergies to ragweed or chrysanthemums.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Elimex (topical Permethrin) is primarily defined by the drug's minimal systemic absorption and a specific restriction regarding other topical medications.

Systemic Drug-Drug Interactions

Regulatory documentation consistently states that no clinically relevant systemic drug-drug interactions are known or anticipated. This is based on the pharmacokinetic profile, which shows that typically less than two percent of the active ingredient is systemically absorbed following dermal application. Due to this negligible systemic exposure, there is no documented risk of altered clearance, exposure modification (AUC/Cmax), or enzyme-mediated interactions (such as CYP or transporter effects) with co-administered systemic medications. No specific systemic drugs or drug classes are listed in official labeling as contraindicated combinations based on interaction risk.

Topical Interaction and Administration Restriction

A pharmacodynamic restriction exists concerning co-administration with other topical products. Official regulatory labeling specifies that topical corticosteroids should be withheld prior to treatment with Elimex cream. This mandatory timing separation is required because the use of corticosteroids is documented to carry a potential risk of exacerbating the underlying parasitic infestation by interfering with the host’s immune response to the mite.

Non-Medicinal Product Interactions

Furthermore, official regulatory documents state that no interactions have been established or documented with food, alcohol, or herbal products.

Mechanism of Action

Modulating Arthropod Sodium Channels for Neurotoxicity

The mechanism of action involves the targeted disruption of nerve function in the ectoparasite. The active ingredient, Permethrin, acts as an allosteric modulator that binds to the voltage-gated sodium channels ( VGSCs) located in the parasite's nerve cell membranes. This critical interaction prevents the channels from properly inactivating, locking them into a prolonged open state and leading to a persistent, uncontrolled influx of sodium ions ( Na^+).

Mechanistic Cascade: Hyperexcitation to Flaccid Paralysis

This molecular binding triggers an irreversible mechanistic cascade. The sustained Na^+ influx causes intense hyperexcitation and uncontrolled firing of the nerve cells, disrupting the central and peripheral nervous system signaling. This excessive activity quickly progresses to motor incoordination and culminates in flaccid paralysis of the entire organism, including the respiratory musculature. The resulting physiological effect is the permanent cessation of the ectoparasite’s essential life functions.

Selective Action and Mechanism Limitations

The drug exhibits selective toxicity due to the intrinsic structural differences between arthropod and mammalian VGSCs, combined with the human body's capacity for rapid metabolic detoxification. The mechanism's functional effectiveness can be constrained by intrinsic resistance factors in the ectoparasite, specifically genetic mutation of the sodium channel (reducing Permethrin binding) and enhanced metabolic detoxification (e.g., via P450 enzymes) which rapidly inactivates the compound.

Dosage and Administration Information

Elimex is administered exclusively by the topical route onto the skin or scalp, with the proper usage protocol determined by the specific parasitic condition being addressed. The medicine is supplied in two standard formulations: a Permethrin Cream 5% w/w for the management of scabies and a Permethrin Lotion 1% for the management of head lice.

The administration of the 5% cream for scabies is typically a single application. For adults, the cream is applied from the neck to the soles of the feet, generally using up to 30 grams, with a maximum permitted dose of 60 grams for comprehensive coverage. Crucially, the cream must maintain skin contact for a specified duration of 8 to 14 hours before being washed off. Application must occur on skin that is clean, dry, and cool.

The 1% lotion for head lice requires a separate, time-limited procedure. The hair is first washed with a non-conditioning shampoo, and the product is then applied to saturate the damp hair and scalp. The required contact time for the lotion is precisely 10 minutes, after which it must be rinsed thoroughly with water.

For both indications, the treatment protocol is based on a single course. A second application for either scabies or lice is indicated only if live parasites are observed 7 to 14 days following the initial use. There are also population-specific adjustments. The 5% cream is approved for use in children 2 months of age and older, and older adult patients apply the cream to the face, ears, and scalp, unlike the standard adult application.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Elimex

Evidence for Use in Scabies Infestation

The research exploring Elimex for scabies infestation is largely built on Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews. These studies primarily focused on measuring how the treatment was associated with two key outcomes: the Clinical Cure Rate, which monitors the status of skin lesions, and the Microscopic Cure, which is the confirmation of the absence of mites or eggs. This research was studied for use in adults and children diagnosed with classical scabies.

Studies and reviews reported various measurements of clearance in the observed populations at follow-up intervals, typically 14 to 28 days after treatment. Comparative trials often explored how the findings for topical Elimex formulations differed from those observed with other treatments. Research indicated that patient-reported outcomes related to physical discomfort, such as pruritus (itching), were sometimes recorded even after microscopic clearance was observed.

Evidence for Use in Pediculosis (Lice Infestations)

Research on Elimex for pediculosis (lice infestations) was studied for use against head lice, body lice, and pubic lice. The primary evidence base includes Randomized Controlled Trials and their associated Systematic Reviews. These studies primarily examined the Lice-Free Proportion—measuring the absence of live lice at follow-up—as well as the clearance of nits (eggs).

Early research described patterns of clearance measurements in the observed populations. However, later scientific reviews reported that the measured clearance rates have declined in many regions. These findings indicate that the medicine's performance appears to vary significantly by location.

Areas of Uncertainty and Research Gaps

Key limitations are consistently acknowledged in the scientific literature. Follow-up durations were limited in many pivotal trials, meaning the long-term effects and the durability of the treatment outcomes are not fully established. Most importantly, the research highlights the variable presence of parasite resistance, especially concerning lice, which introduces a major degree of uncertainty regarding the consistency of reported findings when applied globally. This resistance issue means that results apply most reliably only to the specific populations studied at the time and location of the research.

Key Studies & References

  1. Permethrin Topical - NIH MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Elimex (FAQ)

Q: Is Elimex available over the counter, or is it prescription only?

The regulatory status of Permethrin products can vary depending on the concentration and the country where they are marketed. Official product information indicates that lower concentrations, such as the 1% lotion, are often available over-the-counter.

The higher concentration 5% cream used for certain infestations is frequently classified as prescription-only.

Q: Can Elimex be used by people who have mild kidney problems?

Official information about the drug's action shows that only a very small amount of the active ingredient, typically less than 2%, is absorbed into the body after skin application. This minimal absorption is then quickly broken down into inactive substances that are excreted.

Due to this low level of systemic exposure, official information suggests that altered risk related to mild kidney function is not a documented concern in product labeling.

Q: Does the time of day I take Elimex matter?

The instructions in official product documentation do not specify a particular time of day for application. The product is designed to be applied to clean, dry, and cool skin.

It requires a specific contact time on the affected area, which can range from 10 minutes to 8–14 hours, depending on the specific product formulation being used.

Q: What should I do if I think I am experiencing a side effect from Elimex?

Regulatory documents indicate that if any irritation or symptoms persist, or if a serious allergic reaction occurs, a healthcare professional should be consulted.

Instructions also describe washing the cream off promptly with soap and warm water if too much is applied.

Q: Is it true that Elimex is a relatively new drug on the market?

No, the active ingredient, Permethrin, is not a new compound. Official marketing information shows that products containing Permethrin have been available for many years.

For instance, the 5% cream formulation has been approved in the US since the late 1990s, and the 1% product has been available without a prescription even longer.

Q: Can Elimex impact the results of common lab tests?

Studies indicate that the medicine is absorbed only minimally (less than 2%) into the bloodstream and is rapidly broken down into inactive compounds. Because of this negligible systemic exposure, official product information does not document clinically relevant effects that would alter the results of common laboratory tests.

Q: Why is Elimex not recommended for people with severe liver disease?

Official information notes that the small amount of Permethrin that is absorbed into the body is quickly metabolized, or broken down, by the liver. While the systemic absorption is minimal, the drug's reliance on liver metabolism may be the basis for caution regarding use in cases of severe liver impairment.

Q: How is Elimex excreted from the body?

According to the official product information, the small percentage of the active ingredient that is absorbed into the body is quickly broken down through a process called hydrolysis.

The resulting inactive metabolites are then primarily removed from the body through excretion in the urine.

Q: Is Elimex effective for all stages of the condition it is prescribed for?

The medicine is indicated for the treatment of parasitic infestations. For conditions like scabies, research supporting its use measured success by confirming the absence of mites or eggs (Microscopic Cure) at follow-up intervals.

Q: Are there known generic versions of Elimex currently available?

Yes, official regulatory approval records confirm that the active ingredient Permethrin is available under multiple generic product names.

This is evidenced by the approval of several Abbreviated New Drug Applications (ANDAs) for the 5% cream formulation.

How should Elimex be stored and disposed of?

How to Store and Dispose of Elimex?

Official regulatory guidelines for Permethrin topical products dictate specific conditions for storage and disposal to ensure stability and safety.

Storage and Handling

  • Temperature: Store the product at controlled room temperature, typically between 15 C and 30 C (59 F and 86 F). The product must not be frozen.
  • Container: Keep the container tightly closed and store the medicine in its original packaging.
  • Child Safety: All unused and in-use medicine must be kept out of the sight and reach of children.
  • Special Warning: Keep the product and treated fabrics away from heat and flame, as the fabric can be easily ignited.

Disposal

  • Any remaining product should be discarded immediately after use.
  • Dispose of the unused or expired medicine and its packaging in accordance with national and local regulations for medicinal waste, ensuring that the product does not contaminate water sources.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Elimex found in:

A-Z Index: